Nivestym
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Neupogen | SOLUTION, INJECTABLE | 300 mcg/ 0.5 mL | |
| Neupogen | SOLUTION, INJECTABLE | 480 mcg/1.6 mL | |
| Nivestym | SOLUTION, INJECTABLE | aafi 300 mcg/mL | |
| Nivestym | SOLUTION, INJECTABLE | aafi 480 mcg/1.6 mL | |
| Nypozi Prefilled Syringe | SOLUTION, INJECTABLE | txid 300 mcg/0.5 mL | |
| Nypozi Prefilled Syringe | SOLUTION, INJECTABLE | txid 480 mcg/0.8 mL | |
| Releuko | SOLUTION, INJECTABLE | ayow 300 mcg/0.5 mL | |
| Releuko | SOLUTION, INJECTABLE | ayow 480 mcg/0.8 mL | |
| Zarxio | SOLUTION, INJECTABLE | sndz 300 mcg/0.5 mL | |
| Zarxio | SOLUTION, INJECTABLE | sndz 480 mcg/0.8 mL | |
| Neupogen SingleJect | SOLUTION, INJECTABLE | 300 mcg/0.5 mL |
Releuko (filgrastim-ayow) is the inpatient preferred filgrastim product in Legacy Hospitals.
Nivestym (filgrastim- aafi) may be used for pediatric doses, since this is supplied in a vial rather than prefilled syringe (conducive to pediatric dosing).